Only in America does half of every dollar spent on brand medicines go to entities that don't make

them. While PBMs and 340B hospitals drive up costs, America's biopharmaceutical companies are doing

what these middlemen don't, investing $500 billion in new infrastructure and manufacturing

here at home and helping patients buy medicines directly at lower prices.

Tell Washington to end middlemen markups and put American patients first.

Visit phrm.org slash middlemen.

Hello, hello, and welcome to a very special episode of The Conversation.

I just wrapped up an interview with President Donald Trump here at the White House.

We spoke for about 45 minutes about the seismic impact that he is having all over the world,

especially right now in Europe.

When it comes to the Ukraine-Russia War, when it comes to his relationship with our longtime allies,

and a significant shift that his administration is looking to see on the European continent.

We talked about Venezuela, of course, and then those domestic issues that are so important to Americans every day right now.

That's talking about cost of living and affordability.

That's talking about health care and those Obamacare subsidies that are set to expire at the end of the year. It was a wide

ranging conversation. Here is my interview with President Donald Trump. Mr. President,

thank you so much for joining the conversation.

Thank you.

So Politico has named you as the most influential person shaping Europe as part of our annual Politico 28 list.

Past names that have topped the list include President Zelensky, Prime Minister Georgia Maloney, and President Victor Orban. This year, Politico

broke precedent to recognize an American for the first time in the history of P28. And, sir,

there is no question that you are having seismic impact on the continent and its politics.

...